Molina Healthcare, Inc. (NYSE:MOH) – Research analysts at SunTrust Banks cut their Q1 2020 earnings estimates for Molina Healthcare in a note issued to investors on Tuesday, February 11th. SunTrust Banks analyst D. Macdonald now expects that the company will post earnings per share of $2.81 for the quarter, down from their previous estimate of $3.31. SunTrust Banks also issued estimates for Molina Healthcare’s Q2 2020 earnings at $3.15 EPS and Q3 2020 earnings at $2.97 EPS.
Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Monday, February 10th. The company reported $2.73 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.65 by $0.08. Molina Healthcare had a net margin of 4.38% and a return on equity of 41.71%. The firm had revenue of $4.27 billion during the quarter, compared to analyst estimates of $4.28 billion. During the same quarter in the prior year, the firm posted $3.07 earnings per share. Molina Healthcare’s quarterly revenue was down 8.4% on a year-over-year basis.
A number of other equities research analysts have also issued reports on MOH. Jefferies Financial Group lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating and dropped their price objective for the company from $133.00 to $120.00 in a report on Wednesday, October 30th. Cfra upped their price objective on shares of Molina Healthcare from $128.00 to $141.00 and gave the company a “hold” rating in a report on Tuesday. Deutsche Bank upped their price objective on shares of Molina Healthcare from $145.00 to $150.00 and gave the company a “buy” rating in a report on Tuesday, January 7th. ValuEngine lowered shares of Molina Healthcare from a “hold” rating to a “sell” rating in a report on Saturday, January 4th. Finally, JPMorgan Chase & Co. increased their target price on shares of Molina Healthcare from $150.00 to $152.00 and gave the stock an “overweight” rating in a research note on Friday, December 20th. Two analysts have rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the stock. Molina Healthcare currently has an average rating of “Hold” and an average price target of $152.10.
Shares of MOH opened at $144.99 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.80. Molina Healthcare has a 12-month low of $106.50 and a 12-month high of $159.00. The firm has a 50-day moving average price of $134.77 and a 200 day moving average price of $127.97. The firm has a market capitalization of $8.11 billion, a P/E ratio of 12.64, a P/E/G ratio of 1.15 and a beta of 1.15.
Hedge funds have recently made changes to their positions in the business. BlackRock Inc. boosted its stake in shares of Molina Healthcare by 0.4% in the second quarter. BlackRock Inc. now owns 5,752,811 shares of the company’s stock valued at $823,458,000 after purchasing an additional 22,368 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Molina Healthcare by 105.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,042,744 shares of the company’s stock valued at $141,490,000 after purchasing an additional 534,757 shares during the period. Victory Capital Management Inc. boosted its stake in shares of Molina Healthcare by 3,621.0% in the fourth quarter. Victory Capital Management Inc. now owns 1,032,913 shares of the company’s stock valued at $127,017,000 after purchasing an additional 1,005,154 shares during the period. Boston Partners boosted its stake in shares of Molina Healthcare by 60.1% in the third quarter. Boston Partners now owns 927,312 shares of the company’s stock valued at $101,789,000 after purchasing an additional 348,151 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Molina Healthcare by 8.0% in the fourth quarter. Bank of New York Mellon Corp now owns 739,655 shares of the company’s stock valued at $100,363,000 after purchasing an additional 54,707 shares during the period. 95.64% of the stock is owned by institutional investors.
In other Molina Healthcare news, Director Dale B. Wolf sold 3,500 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $135.51, for a total transaction of $474,285.00. Following the completion of the transaction, the director now owns 8,461 shares of the company’s stock, valued at $1,146,550.11. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.77% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Featured Article: What is a Swap?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.